Brief: PCI Biotech Q4 Comprehensive Loss Narrows To NOK 6.7 Mln
Feb 17 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* Q4 COMPREHENSIVE LOSS NOK 6.7 MILLION VERSUS LOSS NOK 25.0
MILLION YEAR AGO
* Q4 NET FINANCIAL RESULT NOK 364,000 MILLION VERSUS LOSS
NOK 1.8
MILLION YEAR AGO
Source text for Eikon: ID:nGNE5DtGPG
Further company coverage: PCIB.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process